6509NCM249678: OCLACITINIB MALEATE TABLETS.
The OCLACITINIB MALEATE TABLETS is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: OCLACITINIB MALEATE TABLET (APOQUEL) 5.4MG BOTTLE OF 100EA. This part is cataloged in the U.S.
Government catalog under NSN 6509-01-719-4991, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | OCLACITINIB MALEATE TABLET (APOQUEL) 5.4MG BOTTLE OF 100EA |
| NSN | 6509-01-719-4991 |
| SPECIAL FEATURES | CONTROL OF PRURITUS ASSOCIATED WITH ALLERGIC DERMATITIS AND CONTROL OF ATOPIC DERMATITIS IN DOGS; FOR ORAL USE IN DOGS ONLY; 5.4MG TABLETS; STORED AT CONTROLLED ROOM TEMPERATURE BETWEEN 20DEG - 25DEG C (68DEG - 77DEG F) WITH EXCURSIONS BETWEEN 15DEG - 40DEG C (59DEG - 104DEG F); BOTTLE OF 100 TABLETS; FOR ORAL USE IN DOGS ONLY. SHELF LIFE: 36 MONTHS. DEGC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | OCLACITINIB MALEATE TABLET (APOQUEL) 5.4MG BOTTLE OF 100EA |